The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2020

Filed:

Jul. 24, 2017
Applicant:

Marine Biomedical Research Institute of Qingdao Co., Ltd., Shandong, CN;

Inventors:

Wenbao Li, Shandong, CN;

Shixiao Wang, Shandong, CN;

Zhongpeng Ding, Shandong, CN;

Yingwei Hou, Shandong, CN;

Huashi Guan, Shandong, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/06 (2006.01); A61P 35/00 (2006.01); A61K 31/496 (2006.01); A61P 31/10 (2006.01);
U.S. Cl.
CPC ...
C07D 403/06 (2013.01); A61K 31/496 (2013.01); A61P 31/10 (2018.01); A61P 35/00 (2018.01); C07B 2200/13 (2013.01);
Abstract

A polycrystalline form of a dehydrophenylahistin-like compound, and a manufacturing and purification method and application thereof. A (3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)deuteromethylene]piperazine-2,5-dione monohydrate crystal and a (3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylene]piperazine-2,5-dione monohydrate crystal are more competitive crystalline forms with stable quality. The manufacturing and purification method is simple and easy to operate, and can effectively control the generation of a trans-isomer contaminant to obtain a high purity product. The polycrystalline form of the dehydrophenylahistin-like compound has a certain value in an application for manufacturing an antitumor pharmaceutical product.


Find Patent Forward Citations

Loading…